These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 33753734)

  • 1. The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells.
    Cascella R; Chen SW; Bigi A; Camino JD; Xu CK; Dobson CM; Chiti F; Cremades N; Cecchi C
    Nat Commun; 2021 Mar; 12(1):1814. PubMed ID: 33753734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
    Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
    Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Release of Toxic Oligomers from α-Synuclein Fibrils with Antibodies and STED Microscopy.
    Bigi A; Ermini E; Chen SW; Cascella R; Cecchi C
    Life (Basel); 2021 May; 11(5):. PubMed ID: 34064766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
    Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
    Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity.
    Yang X; Williams JK; Yan R; Mouradian MM; Baum J
    Sci Rep; 2019 Nov; 9(1):17579. PubMed ID: 31772376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
    Candreva J; Chau E; Rice ME; Kim JR
    Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
    Alam P; Bousset L; Melki R; Otzen DE
    J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.
    Dhakal S; Wyant CE; George HE; Morgan SE; Rangachari V
    J Mol Biol; 2021 May; 433(10):166953. PubMed ID: 33771571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
    Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
    Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
    Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
    J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.
    Luk KC; Song C; O'Brien P; Stieber A; Branch JR; Brunden KR; Trojanowski JQ; Lee VM
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20051-6. PubMed ID: 19892735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glimpse into the structural properties of α-synuclein oligomers.
    Santos J; Pallarès I; Ventura S
    Biofactors; 2024; 50(3):439-449. PubMed ID: 38063360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals.
    Borsarelli CD; Falomir-Lockhart LJ; Ostatná V; Fauerbach JA; Hsiao HH; Urlaub H; Paleček E; Jares-Erijman EA; Jovin TM
    Free Radic Biol Med; 2012 Aug; 53(4):1004-15. PubMed ID: 22771470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A53T mutant α-synuclein fibrils formed in macrophage are spread to neurons.
    Moriya S; Hanazono M; Fukuhara T; Iwase K; Hattori N; Takiguchi M
    Cell Mol Life Sci; 2022 Apr; 79(5):234. PubMed ID: 35397671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies.
    Cascella R; Bigi A; Cremades N; Cecchi C
    Cell Mol Life Sci; 2022 Mar; 79(3):174. PubMed ID: 35244787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.
    Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI
    Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruptive membrane interactions of alpha-synuclein aggregates.
    Iyer A; Claessens MMAE
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):468-482. PubMed ID: 30315896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models.
    Karpinar DP; Balija MB; Kügler S; Opazo F; Rezaei-Ghaleh N; Wender N; Kim HY; Taschenberger G; Falkenburger BH; Heise H; Kumar A; Riedel D; Fichtner L; Voigt A; Braus GH; Giller K; Becker S; Herzig A; Baldus M; Jäckle H; Eimer S; Schulz JB; Griesinger C; Zweckstetter M
    EMBO J; 2009 Oct; 28(20):3256-68. PubMed ID: 19745811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.